Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.
Crohn’s disease
Mendelian randomization
inflammatory bowel disease
psoriasis
psoriatic arthritis
ulcerative colitis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
04
2022
accepted:
16
05
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
29
6
2022
Statut:
epublish
Résumé
Previous observational studies have found an association between inflammatory bowel disease (IBD) and psoriasis. Using the mendelian randomization (MR) approach, we aim to determine whether there was a causal association between IBD and psoriasis. We performed a two-sample MR with the genetic instruments identified for IBD and its main subtypes, Crohn's disease (CD) and ulcerative colitis (UC), from a genome-wide association study (GWAS) involving 25,042 cases with an IBD diagnosis and 34,915 controls. Summarized data for psoriasis were obtained from different GWAS studies which included 4510 cases and 212,242 controls without psoriasis. Causal estimates are presented as odds ratios (ORs) with 95% confidence intervals (CIs). The overall outcome of MR analysis was to demonstrate that genetic predisposition to IBD was associated with an increased risk of psoriasis (OR: 1.1271; 95% CI: 1.0708 to 1.1864). Psoriatic arthritis (PsA) had a significant association with total IBD (OR: 1.1202; 95% CI: 1.0491 to 1.1961). Casual relationship was also identified for CD-psoriasis (OR: 1.1552; 95% CI: 1.0955 to 1.2182) and CD-PsA (OR: 1.1407; 95% CI: 1.0535 to 1.2350). The bidirectional analysis did not demonstrate that a genetic predisposition to psoriasis was associated with total IBD, although psoriasis showed association with CD (OR: 1.2224; 95% CI: 1.1710 to 1.2760) but not with UC. A genetic predisposition to PsA had a borderline association with IBD (OR: 1.0716; 95% CI: 1.0292 to 1.1157) and a suggestive association with CD (OR: 1.0667; 95% CI: 1.0194 to 1.1162). There appears to be a causal relationship between IBD and psoriasis, especially for PsA, but for psoriasis and IBD, only total psoriasis and PsA were associated with CD. Understanding that specific types of psoriasis and IBD constitute mutual risk factors facilitates the clinical management of two diseases.
Sections du résumé
Background
Previous observational studies have found an association between inflammatory bowel disease (IBD) and psoriasis. Using the mendelian randomization (MR) approach, we aim to determine whether there was a causal association between IBD and psoriasis.
Methods
We performed a two-sample MR with the genetic instruments identified for IBD and its main subtypes, Crohn's disease (CD) and ulcerative colitis (UC), from a genome-wide association study (GWAS) involving 25,042 cases with an IBD diagnosis and 34,915 controls. Summarized data for psoriasis were obtained from different GWAS studies which included 4510 cases and 212,242 controls without psoriasis. Causal estimates are presented as odds ratios (ORs) with 95% confidence intervals (CIs).
Results
The overall outcome of MR analysis was to demonstrate that genetic predisposition to IBD was associated with an increased risk of psoriasis (OR: 1.1271; 95% CI: 1.0708 to 1.1864). Psoriatic arthritis (PsA) had a significant association with total IBD (OR: 1.1202; 95% CI: 1.0491 to 1.1961). Casual relationship was also identified for CD-psoriasis (OR: 1.1552; 95% CI: 1.0955 to 1.2182) and CD-PsA (OR: 1.1407; 95% CI: 1.0535 to 1.2350). The bidirectional analysis did not demonstrate that a genetic predisposition to psoriasis was associated with total IBD, although psoriasis showed association with CD (OR: 1.2224; 95% CI: 1.1710 to 1.2760) but not with UC. A genetic predisposition to PsA had a borderline association with IBD (OR: 1.0716; 95% CI: 1.0292 to 1.1157) and a suggestive association with CD (OR: 1.0667; 95% CI: 1.0194 to 1.1162).
Conclusion
There appears to be a causal relationship between IBD and psoriasis, especially for PsA, but for psoriasis and IBD, only total psoriasis and PsA were associated with CD. Understanding that specific types of psoriasis and IBD constitute mutual risk factors facilitates the clinical management of two diseases.
Identifiants
pubmed: 35757704
doi: 10.3389/fimmu.2022.916645
pmc: PMC9226443
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
916645Informations de copyright
Copyright © 2022 Li, Guo, Cao and Wu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Epidemiol. 2017 May;32(5):377-389
pubmed: 28527048
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
Int J Rheum Dis. 2020 Oct;23(10):1288-1296
pubmed: 32761870
Int J Rheum Dis. 2020 Oct;23 Suppl 1:3-353
pubmed: 33135849
JAMA. 2021 Oct 26;326(16):1614-1621
pubmed: 34698778
Int J Rheum Dis. 2017 Sep;20(9):1212-1218
pubmed: 25363664
Lancet. 2021 Apr 3;397(10281):1301-1315
pubmed: 33812489
J Am Acad Dermatol. 2021 Aug;85(2):396-403
pubmed: 31415837
Annu Rev Immunol. 2010;28:573-621
pubmed: 20192811
Rheumatology (Oxford). 2021 Dec 24;61(1):e32
pubmed: 34647979
N Engl J Med. 2002 Aug 8;347(6):417-29
pubmed: 12167685
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
BMJ. 2020 May 28;369:m1590
pubmed: 32467098
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Am J Hum Genet. 2012 Apr 6;90(4):636-47
pubmed: 22482804
Arthritis Rheumatol. 2022 Mar;74(3):546-547
pubmed: 34463055
Am J Epidemiol. 2018 Dec 1;187(12):2681-2685
pubmed: 30188969
Arthritis Rheumatol. 2016 Apr;68(4):915-23
pubmed: 26555117
Genet Epidemiol. 2020 Jun;44(4):313-329
pubmed: 32249995
Lancet. 2007 Jul 21;370(9583):263-271
pubmed: 17658397
BMJ. 2018 Jul 12;362:k601
pubmed: 30002074
Int J Rheum Dis. 2019 Apr;22(4):700-707
pubmed: 30666824
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
JAMA Dermatol. 2018 Dec 1;154(12):1417-1423
pubmed: 30422277
J Am Acad Dermatol. 2017 Mar;76(3):377-390
pubmed: 28212759
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Nat Genet. 2018 May;50(5):693-698
pubmed: 29686387
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
J Crohns Colitis. 2020 Mar 13;14(3):351-360
pubmed: 31504363
Eur Psychiatry. 2019 Aug;60:79-85
pubmed: 31234011
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
J Formos Med Assoc. 2021 Mar;120(3):926-938
pubmed: 33012636
J Autoimmun. 2017 Mar;78:29-38
pubmed: 27965059
Int J Rheum Dis. 2019 Sep;22(9):1686-1694
pubmed: 31328410
Lancet Digit Health. 2019 Jul;1(3):e101-e103
pubmed: 33323255
Front Genet. 2021 Nov 17;12:727475
pubmed: 34868204
Inflamm Bowel Dis. 2007 Jul;13(7):807-21
pubmed: 17262812
J Rheumatol. 2015 Aug;42(8):1439-42
pubmed: 26077408
Curr Epidemiol Rep. 2017;4(4):330-345
pubmed: 29226067
Int J Mol Sci. 2020 Nov 30;21(23):
pubmed: 33266237
J Am Coll Cardiol. 2015 Apr 21;65(15):1552-61
pubmed: 25770315
Biomed Res Int. 2013;2013:983902
pubmed: 23971052